Archives
PCORI and NHC Congressional Briefing 2026, Washington DC
AHF was proud to represent the HDFN community at a Congressional briefing on Capitol Hill hosted by PCORI and the National Health Council. Our Director of Research, Molly Sherwood, joined patients, families, and advocacy leaders from across the rare disease community to discuss the critical role of meaningful patient engagement in clinical research and patient-centered… Read More »
Bethany Weathersby, Executive Director of AHF, receives THOR Impact Award, 2026
At the 2026 THOR Annual Scientific Meeting, Allo Hope Foundation Executive Director, Bethany Weathersby, was presented with the THOR Impact Award for her international leadership and unwavering commitment to improving outcomes for women, babies, and families affected by HDFN.
THOR 2026, Dublin Ireland
AHF was proud to participate in the 2026 THOR Annual Symposium in Ireland. Bringing together civilian and military clinicians, transfusion medicine experts, researchers, and innovators from more than 30 countries, the symposium fostered collaboration and shared the latest advances in trauma resuscitation, whole blood, and transfusion science. We were honored to contribute the patient perspective… Read More »
International Alloimmune Conference 2026, Amsterdam
AHF was proud to participate in the 2nd International Alloimmune Conference on HDFN in Leiden, joining clinicians, researchers, laboratory experts, patients and industry partners from more than 30 countries. Our AHF Ambassador to Kenya, Rose Murage, gave an opening presentation on the lived experience and her patient journey in Africa. Together, we continued working toward… Read More »
2026 World Alloimmunization and HDFN Awareness Day
March 12 is World Alloimmunization and HDFN Awareness Day! Four years ago we founded this global awareness day to bring much needed education, visibility, and urgency to our rare and often overlooked condition. What began as a simple call for awareness has grown into a powerful movement of families, clinicians, researchers and advocates around the… Read More »
SMFM 2026, Las Vegas
AHF was so excited to once again attend the SMFM (Society for Fetal Medicine) Meeting in Las Vegas. We had an amazing time sharing the new evidence-based clinical practice guidelines for red cell alloimmunized pregnancies and connecting with MFM, industry and advocacy partners.
ISBT/Blood 2025, Perth Australia
At the joint ISBT Perth and Blood 2025 meeting, AHF’s Director of Research, Molly Sherwood, took the stage to present the HDFN Consensus Guidelines, reinforcing AHF’s global impact and ongoing committment to collaboration and education in the field of transfusion medicine.
Bethany Receives 2025 AABB Presidents Award
Our Executive Director, Bethany Weathersby, received the 2025 AABB Presidents Award at the AABB Annual Meeting in San Diego. Bethany was recognized for “important advocacy that has advanced the care of women and children affected by blood incompatibility.” Please join us in congratulating Bethany! Read more here.
2025 AABB Annual Meeting, San Diego, CA
The Allo Hope Foundation was honored to once again attend the AABB (Association for the Advancement of Blood and Biotherapies) 2025 Annual Meeting in San Diego. Our Executive Director, Bethany Weathersby, presented information about the new HDFN Consensus Guidelines in the AABB/THOR Joint Session on Saturday October 25. Our Director of Development, Katie Shanahan, presented… Read More »
PPTA Panel 2025, Washington DC
The Allo Hope Foundation was proud to participate in the Plasma Protein Forum’s “Driving Awareness & Action for Anti-D” session, hosted by the Plasma Protein Therapeutics Association (PPTA). Our Director of Development, Katie Shanahan, joined a diverse panel of experts, including clinicians, industry leaders, and plasma donors, to discuss the global challenges and opportunities surrounding… Read More »
